The Clinical Pharmacology of Anastrozole

@article{Bao2011TheCP,
  title={The Clinical Pharmacology of Anastrozole},
  author={Ting Bao and Michelle A Rudek},
  journal={European Oncology and Haematology},
  year={2011},
  volume={07},
  pages={106}
}
  • Ting Bao, Michelle A Rudek
  • Published 2011
  • Medicine
  • European Oncology and Haematology
    • View PDF
    13 Citations
    Background Citations
    2
    Methods Citations
    1

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

        13 Citations
        Citation Type

        Citation Type

        Anti-cancer Potential of Moringa oleifera on BRCA1 Gene: Systems Biology
        • PDF
        Anastrozole as aromatase inhibitor – new approaches to breast cancer treatment in postmenopausal women
        • PDF
        Cytotoxic effect of transdermal invasomal anastrozole gel on MCF-7 breast cancer cell line
        • 3
        • PDF
        EFFECTS OF ANASTROZOLE ADMINISTRATION ON SERUM ESTROGEN LEVEL OF FEMALE RABBIT
        • PDF
        Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer
        • 14
        Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells
        • 6
        • PDF
        Evaluation of Breast Cancer in Reference to Skin Changes 1
        • Dr. Mritunjay Sarawgi, Dr. Sushil Singh, Dr. Anjay Kumar, Dr. Shalini Ekka, D. S. Kumar
        • 2017
        • PDF
        FUNGAL KAYNAKLI BASSİATİN’İN (3R,6R) MEME KANSERİ HÜCRE HATLARI ÜZERİNDEKİ ETKİSİNİN ARAŞTIRILMASI
        Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
        • 5
        Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification
        • 32
        • PDF

        References

        SHOWING 1-10 OF 32 REFERENCES
        Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast Cancer
        • 13
        Effect of simvastatin on the pharmacokinetics of anastrozole.
        • T. Bao, S. Slater, +5 authors V. Stearns
        • Medicine
        • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
        • 2009
        • 1
        Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
        • 24
        A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
        • 1,447
        • PDF
        American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
        • E. Winer, C. Hudis, +19 authors M. Somerfield
        • Medicine
        • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
        • 2005
        • 991
        Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol
        • 128
        Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
        • 193
        Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
        • 437
        • PDF
        A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
        • 1,722
        • PDF
        Arimidex®: A potent and selective fourth-generation aromatase inhibitor
        • 150